INTRODUCTION: Hispanics in New Mexico are diagnosed with more later-stage colorectal cancer (CRC) than non-Hispanic Whites (NHW). Our study evaluated the interaction of race/ethnicity and risk factors for later-stage III and IV CRC among patients in New Mexico. METHOD: CRC patients ages 30 to 75 years ( n = 163, 46% Hispanic) completed a survey on key explanatory clinical, lifestyle, preventive health, and demographic variables for CRC risk. Adjusted logistic regression models examined whether these variables differentially contributed to later-stage CRC among NHW versus Hispanics. RESULTS: Compared with NHW, Hispanics had a higher prevalence of later-stage CRC ( p = .007), diabetes ( p = .006), high alcohol consumption ( p = .002), low education ( p = .003), and CRC diagnosis due to symptoms ( p = .06). Compared with NHW, Hispanics reporting high alcohol consumption (odds ratio [OR] = 7.59; 95% confidence interval [CI] = 1.31-43.92), lower education (OR = 3.5; 95% CI = 1.28-9.65), being nondiabetic (OR = 3.23; 95% CI = 1.46-7.15), or ever smokers (OR = 2.4; 95% CI = 1.03-5.89) were at higher risk for late-stage CRC. Adjusting for CRC screening did not change the direction or intensity of the odds ratios. CONCLUSION: The ethnicity-risk factor interactions, identified for late-stage CRC, highlight significant factors for targeted intervention strategies aimed at reducing the burden of later-stage CRC among Hispanics in New Mexico with broad applicability to other Hispanic populations.
INTRODUCTION: Hispanics in New Mexico are diagnosed with more later-stage colorectal cancer (CRC) than non-Hispanic Whites (NHW). Our study evaluated the interaction of race/ethnicity and risk factors for later-stage III and IV CRC among patients in New Mexico. METHOD: CRC patients ages 30 to 75 years ( n = 163, 46% Hispanic) completed a survey on key explanatory clinical, lifestyle, preventive health, and demographic variables for CRC risk. Adjusted logistic regression models examined whether these variables differentially contributed to later-stage CRC among NHW versus Hispanics. RESULTS: Compared with NHW, Hispanics had a higher prevalence of later-stage CRC ( p = .007), diabetes ( p = .006), high alcohol consumption ( p = .002), low education ( p = .003), and CRC diagnosis due to symptoms ( p = .06). Compared with NHW, Hispanics reporting high alcohol consumption (odds ratio [OR] = 7.59; 95% confidence interval [CI] = 1.31-43.92), lower education (OR = 3.5; 95% CI = 1.28-9.65), being nondiabetic (OR = 3.23; 95% CI = 1.46-7.15), or ever smokers (OR = 2.4; 95% CI = 1.03-5.89) were at higher risk for late-stage CRC. Adjusting for CRC screening did not change the direction or intensity of the odds ratios. CONCLUSION: The ethnicity-risk factor interactions, identified for late-stage CRC, highlight significant factors for targeted intervention strategies aimed at reducing the burden of later-stage CRC among Hispanics in New Mexico with broad applicability to other Hispanic populations.
Authors: Anke M Leufkens; Fränzel J B Van Duijnhoven; Peter D Siersema; Hendriek C Boshuizen; Alina Vrieling; Antonio Agudo; Inger T Gram; Elisabete Weiderpass; Christina Dahm; Kim Overvad; Anne Tjønneland; Anja Olsen; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Domenico Palli; Sara Grioni; Rosario Tumino; Charlotta Sacerdote; Amalia Mattiello; Silke Herman; Rudolf Kaaks; Annika Steffen; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Petra H Peeters; Carla H van Gils; Henk van Kranen; Eliv Lund; Vanessa Dumeaux; Dagrun Engeset; Laudina Rodríguez; Maria-José Sánchez; Maria-Dolores Chirlaque; Aurelio Barricarte; Jonas Manjer; Martin Almquist; Bethany van Guelpen; Göran Hallmans; Kay-Tee Khaw; Nick Wareham; Konstantinos K Tsilidis; Kurt Straif; Maria Leon-Roux; Paul Vineis; Teresa Norat; Elio Riboli; H Bas Bueno-de-Mesquita Journal: Clin Gastroenterol Hepatol Date: 2010-10-26 Impact factor: 11.382
Authors: Richard M Hoffman; David K Espey; Robert L Rhyne; Melissa Gonzales; Ashwani Rajput; Shiraz I Mishra; S Noell Stone; Charles L Wiggins Journal: J Cancer Epidemiol Date: 2014-01-02
Authors: Parisa Malekzadeh; Rami Yossef; Gal Cafri; Biman C Paria; Frank J Lowery; Mohammad Jafferji; Meghan L Good; Abraham Sachs; Amy R Copeland; Sanghyun P Kim; Scott Kivitz; Maria R Parkhurst; Paul F Robbins; Satyajit Ray; Liqiang Xi; Mark Raffeld; Zhiya Yu; Nicholas P Restifo; Robert P T Somerville; Steven A Rosenberg; Drew C Deniger Journal: Clin Cancer Res Date: 2020-01-29 Impact factor: 12.531
Authors: Echo L Warner; Laura Martel; Judy Y Ou; Gina E Nam; Sara Carbajal-Salisbury; Virginia Fuentes; Anne C Kirchhoff; Deanna Kepka Journal: J Community Health Date: 2019-04
Authors: Angelina R Wittich; L Aubree Shay; Belinda Flores; Elisabeth M De La Rosa; Taylor Mackay; Melissa A Valerio Journal: AIMS Public Health Date: 2019-04-01
Authors: Charles R Rogers; Ellen Brooks; Karen Curtin; Mary A De Vera; Fares Qeadan; Tiana N Rogers; Ethan Petersen; Phuong Gallagher; Curt Pesmen; Wenora Johnson; Candace Henley; Walter Hickman; Elaine Newcomb; Kevin M Korous; Margaret A Handley Journal: BMJ Open Date: 2021-12-03 Impact factor: 2.692
Authors: C L De La Torre; J N Dumbauld; J Haughton; S Gupta; J Nodora; R Espinoza Giacinto; C Ramers; B Bharti; K Wells; J Lopez; M Díaz; J Moody; Elva M Arredondo Journal: Hisp Health Care Int Date: 2020-05-29
Authors: Anjana E Sharma; Helena C Lyson; Roy Cherian; Ma Somsouk; Dean Schillinger; Urmimala Sarkar Journal: J Patient Saf Date: 2022-01-01 Impact factor: 2.243